A Common Deworming Drug Slowed Resistant Lung Cancer Tumors in Mice
A medicine commonly used to treat intestinal worm infections has caught researchers’ attention for an unexpected reason. When combined with a targeted lung cancer drug, it helped slow the growth of tumors that had stopped responding to treatment in a study involving mice. The findings, published in PLOS ONE, raise an intriguing possibility for researchers …